REVIEW
The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis
Article first published online: 31 MAR 2010
DOI: 10.1111/j.1476-5381.2010.00789.x
© 2010 The Authors. Journal compilation © 2010 The British Pharmacological Society
Additional Information
How to Cite
Cadwallader, A. B., De La Torre, X., Tieri, A. and Botrè, F. (2010), The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis. British Journal of Pharmacology, 161: 1–16. doi: 10.1111/j.1476-5381.2010.00789.x
Publication History
- Issue published online: 18 AUG 2010
- Article first published online: 31 MAR 2010
- Received 11 December 2009; revised 29 January 2010; accepted 19 February 2010
Keywords:
- diuretics; masking agents; doping analysis; GC/MS;
- LC/MS-MS
Diuretics are drugs that increase the rate of urine flow and sodium excretion to adjust the volume and composition of body fluids. There are several major categories of this drug class and the compounds vary greatly in structure, physicochemical properties, effects on urinary composition and renal haemodynamics, and site and mechanism of action. Diuretics are often abused by athletes to excrete water for rapid weight loss and to mask the presence of other banned substances. Because of their abuse by athletes, diuretics have been included on The World Anti-Doping Agency's (WADA) list of prohibited substances; the use of diuretics is banned both in competition and out of competition and diuretics are routinely screened for by anti-doping laboratories. This review provides an overview of the pharmacology and toxicology of diuretics and discusses their application in sports. The most common analytical strategies currently followed by the anti-doping laboratories accredited by the WADA are discussed along with the challenges laboratories face for the analysis of this diverse class of drugs.

1476-5381/asset/olbannerleft.gif?v=1&s=198ba9e64c782a75183a18cb494f9d10ecc901ea)
1476-5381/asset/olbannerright.gif?v=1&s=0b2124237bd4227e7991f1ea05cd4bed2496a9ae)
